Dec 09, 09:07
AnnouncementsPanacea Biotec: Outcome of EGM
AnnouncementsPanacea Biotec: Updates on EGM on Nov 22, 2013
AnnouncementsPanacea Biotec EGM on November 22, 2013
AnnouncementsPanacea Biotec: Outcome of AGM
Only BuyersOnly Buyers in Panacea Biotec on NSE
AnnouncementsPanacea Biotec fixes book closure for AGM
|Company Name||Last Price||%
|Dr Reddys Labs||2449.50||1.14||2545.00||1764.00||41,665.93|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Panacea Biotec is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 627.82 crore.The company has reported a standalone sales of Rs 110.09 crore and a Net Loss of Rs 56.27 crore for the quarter ended Sep 2013.
The company management includes Soshil Kumar Jain - Chairman, Ravinder Jain - Managing Director, Rajesh Jain - Joint Managing Director, Sandeep Jain - Joint Managing Director, Sumit Jain - Director, R L Narasimhan - Independent Director, N N Khamitkar - Independent Director, Sunil Kapoor - Independent Director, K M Lal - Independent Director, A N Saksena - Independent Director.
It is listed on the BSE with a BSE Code of 531349 and the NSE with an NSE Code of PANACEABIO.
Its Registered office is at Ambala-Chandigarh Highway , Lalru,Punjab - 140501.
Their Registrars are Skyline Financial Services (p) Ltd.